Pharma Two B, an Israeli company which develops fixed-dose combination drugs, has announced that it has raised $8 million in its second financing round. The company says that it will use the funds to continue the development of its early-stage Parkinson’s disease treatment.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments